Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx onl...

FDA Recall #D-0508-2024 — Class I — April 29, 2024

Recall #D-0508-2024 Date: April 29, 2024 Classification: Class I Status: Completed

Product Description

Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36 Stults Road, Dayton, NJ 08810, NDC 63037-123-25

Reason for Recall

Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.

Recalling Firm

Hikma Injectables USA Inc — Dayton, NJ

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Distribution

CO, GA, PA, SD, WA

Code Information

Lot #: 240310003D, Exp 6/4/2024

Status

Completed

Voluntary / Mandated

Voluntary: Firm initiated